June 28th, 2017
With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.
December 29th, 2016
Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]
May 26th, 2010
This is one of those good stories about modern technology helping support the Hippocratic Oath — first, do no harm. In this case, how to avoid a painful treatment when possible. Mayo researchers have found that a subset of patients with stage II colon cancer don’t benefit from standard chemotherapy. They do well with just […]